BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Medium (6M)
Edelweiss Recommends 'Buy' On Lupin
According to Edelweiss, an encouraging respiratory and biosimilar franchise may unlock value for Lupin in the long run. The stock's current valuation factors in the worst-case scenario while ascribing nil value to the US business, where the bulk of investments occur, the brokerage adds.